The nature of the Hodgkin/Reed-Sternberg (H/RS) cells in Hodgkin's disease (HD) is still unclear. We have studied isolated H/RS cells from four cases of lymphocytic predominance (LP) HD and six cases of nodular sclerosis (NS) HD and assayed the cells for immunoglobulin heavy chain (IgH) gene rearrangement by the polymerase chain reaction (PCR). The H/RS cells in all four cases of LPHD had rearranged their IgH gene in a polyclonal pattern. The H/RS cells of three cases of NSHD where at least a fraction of the cells expressed the B-cell marker CD20 had also rearranged their IgH gene. In two of the cases, the rearrangements were totally unrelated while in one case, two out of six rearrangements were identical in sequence indicating the presence of a clonal subpopulation amid a polyclonal background. Clonality was assessed independently in one NSHD case by determining the pattern of X-chromosome inactivation. This technique also failed to show that the H/RS cells were monoclonal. Our studies suggest that in both LPHD and NSHD, the H/RS cells may be a polyclonal proliferation at presentation and clonal populations may emerge from this polyclonal background. There is also some evidence of a correlation between the immunophenotype and the genotype of the H/RS cells. Single cell assays show great potential in elucidating the cell lineage and clonality of H/RS cells, as well as their in vivo evolution during the disease process.
Introduction
It is the general consensus that Hodgkin's disease (HD) is a neoplastic condition and the large pleomorphic cells, Hodgkin/Reed-Sternberg (H/RS) cells, in the tumor are the neoplastic component [1] . However, the nature of the H/RS cells is still not entirely resolved. The difficulty arises in part from the fact that the H/RS cells usually constitute a minor component of the cellular population in the tumor. In addition, there seems to be considerable heterogeneity within the H/RS cell population, not only among different subtypes of HD, but even within the same tumor. Immunohistochemical studies in the last decade have provided strong evidence that the H/RS cells in nodular lymphocytic predominance (N-LP) HD belong to the B-lineage, but lineage derivation of the H/RS cells in the classic HD remains unclear [2] . There is both cytogenetic and molecular evidence for the existence of a clonal population in some Hodgkin's tumors [3] . Studies utilizing Epstein-Barr virus (EBV) as a clonal marker have provided evidence indicating that the H/RS cells constitute the clonal population [4, 5] . However, it has been observed that in some cases of HD showing immunoglobulin heavy chain (IgH) gene rearrangement, the intensity of the rearranged band was lower than one would expect from the proportion of H/RS cell present, raising the possibility that the rearrangement is present in only a subpopulation of the H/RS cells [6] .
In order to make further progress in delineating the lineage and clonality of H/RS cells, we and others have studied single isolated H/RS cells by highly sensitive polymerase chain reaction (PCR)-based assays [7] [8] [9] [10] [11] [12] . Our data suggest that HD may begin as a polyclonal proliferation from which a monoclonal lesion may develop. There is also some correlation between immunophenotype and genotype.
Results
We isolated H/RS cells from four cases of N-LPHD based on their morphology and reactivity with anti-EMA. The immunoglobulin heavy chain (IgH) gene complementarity determining region (CDR) HI of these cells was amplified by the PCR Single small Band T-lymphocytes from the same tissue section acted as positive and negative controls, respectively. In this study, similar proportions of H/RS cells (48%) and small B-cells (44%) showed amplified CDRffl products suggesting that all the H/RS cells had rearranged their IgH genes. This was in agreement with their B-cell phenotype. Interesting, the IgH CDRin amplicons of H/RS cells in each case were not identical as expected of a monoclonal population. In fact, they were all different as seen in polyclonal B-cells [8] .
We later studied six cases of HD of the nodular sclerosis (NS) type. Three of these cases had 5%, 10% and 100% of CD20 + H/RS cells, respectively, while the H/RS cells of the other three cases were CD20~. The H/RS cells were isolated based on their morphology and staining with either CD15 or CD30. The IgH CDRUI was amplified as described above with similar control populations. Only rare H/RS cells from the CD20" cases showed amplifiable products while the other three cases (CD20 + ) showed similar results as the previously studied N-LPHD, except that two cells with identical CDRm amplicons were detected in one of these cases consistent with the presence of a clonal population in a polyclonal background. We further studied one of the female CD20 + cases for evidence of monoclonality by the pattern of inactivation of the human androgen receptor (HUMARA) gene on the X-chromosome [13] . There was no exclusive inactivation of one of the alleles as expected of a monoclonal population [14] .
Discussion
The immunophenotypic evidence for a B-lineage derivation of the H/RS cells of N-LPHD is corroborated by genotypic evidence for B-lineage differentiation, i.e., the complete rearrangement of the IgH gene. However, in none of our cases did we detect a monoclonal population by single cell analysis [8] . With the limited number of cells studied in each case, we cannot exclude the presence of clonal subpopulation(s) in these cases. It also remains to be determined whether cases with numerous H/RS cells or nodules of such cells would more likely show evidence of a clonal population. Our data indicated a fundamental difference between N-LPHD and B-non-Hodgkin's lymphoma (NHL) in that the latter is a monoclonal proliferation at presentation while the former is often not Perhaps, we may consider N-LPHD as a pre-lymphomatous proliferation that has a propensity to evolve into a monoclonal B-NHL. Indeed, large cell lymphomas occur concurrently or subsequently in a substantial proportion of N-LPHD [15] and histiocyte rich-B-cell lymphoma [16] is also frequently associated with N-LPHD. Recently, a clonal relationship between the B-large cell NHL with its associated N-LPHD has been demonstrated in some cases supporting the concept of clonal evolution in N-LPHD [17] . N-LPHD generally has an indolent clinical behavior. Does this chronic course relate to a generally prolonged polyclonal phase and should we reconsider treatment options at this phase? Does the emergence of a major clonal population signify a change or impending change in clinical behavior and hence require a different treatment strategy?
Classic HD is immunophenotypically much more variable than N-LPHD. We studied two groups of NSHD cases to assess whether there is a correlation between immunophenotype and genotype. In the three cases where at least a fraction of the H/RS cells expressed the B-cell antigen CD20, IgH gene rearrangement was also demonstrable in single H/RS cells. Similar to N-LPHD, the rearrangements were not monoclonal. Hummel et al. [12] , using a different technique of cell isolation, obtained similar results with their four cases of CD20 + NSHD. These results that the H/RS cells, in at least a subset of NSHD had undergone complete VDJ rearrangement and appeared to be polyclonal. Again, the number of cells analyzed was too small to exclude the presence of clonal subpopulations. Statistical analysis indicates that 34 cells with IgH gene IgH gene rearrangements need to be analyzed to detect a clonal population constituting 20% or more of the population with a 95% confidence. Indeed, in one of our cases, two clonally related cells out of six analyzed cells were detected indicating the presence of a subclone of considerable size. Similar observations were made in some cases of mixed cellularity HD with a B-cell phenotype in the report by Hummel and coworkers [12] . We considered the possibility that the H/RS cells in these cases might be a clonal population transformed prior to IgH gene rearrangement which occurred randomly later, giving rise to the appearance of polyclonality when the IgH gene rearrangement was used as the criterion for clonality. The pattern of X-chromosome inactivation was used, therefore, as an additional assay for clonality in three female cases. The human androgen receptor gene on the X-chromosome appears to be the best target for the single cell assay [13] . In a case that was successfully studied, the H/RS cells did not inactivate consistently either the paternal or the maternal allele, again indicating the population is not monoclonal. We were able to demonstrate only rare IgH CDRUI rearrangements in the three cases of NSHD with the classic HD phenotype (T", B", CD15 + , CD30 + ). This may mean that the H/RS cells had germline IgH gene, IgH gene with only DJ rearrangement or even a clonal IgH gene rearrangement that was not amplifiable by the primers we used. Hence, we are not able to make any conclusions regarding the lineage and clonality of H/RS cells in these cases.
There have been some conflicting results reported from different research groups utilizing the single cell assay to study H/RS cells [9] [10] [11] [12] . Part of the inconsistency may be related to the techniques employed and part of it may be due to different case selection criteria. If H/RS cells are picked from a tissue section by micromanipulation, it is likely that cells in a limited area of the tumor are being sampled. The possibility that H/RS cells in a geographically confined area, such as in a nodule in N-LP or NSHD, are likely to be clonal or oligoclonal needs to be considered. To address this question, cells from different nodules, especially those that are distant from each other, need to be sampled. Another relevant consideration is the relationship between the abundance of H/RS cells in a tumor and the likelihood of clonality in a case. If these two features are related, the selection of cases with many H/RS cells will yield a much higher incidence of monoclonal lesions. It has been reported [19] that there were HD tumors with rearranged Ig kappa chain only. If the kappa chain is not assayed, such cases will be considered lacking Ig rearrangements. Aside from the above consideration, the problem of contamination is very real in the setting of single cell assays. Contamination may be due to the presence of DNA molecules in the fluid phase rather than in the cellular phase of the sample or the inadvertent aspiration of other cells in addition to the target H/RS cells into the micropipette. With the sensitivity of the PCR assay increased to the level of single molecules, contamination during the assay procedure is an ever present menace and all necessary precautions and controls must be used to safeguard the reliability of the experimental results.
Single cell assay is at this infancy. Several methods have been developed and employed by different groups [8] [9] [10] . The limitations and advantages of each method will become apparent with more experience. This is a powerful technique that has an enormous potential for studying minute specimens, dissecting the heterogeneity of a cellular population and microanalyzing a biological process. The initial discordance of the reported findings in the study of H/RS cells may be more apparent than real and should not detract from the usefulness of this approach. Obviously, to make further progress, more cases and more cells per case need to be studied with great care to avoid contamination and sampling bias. Cases with varying morphology and immunophenotype should be included and correlated with the genotypic study. Sequential biopsies are of great value in determining clonal progression and the potential of H/RS cells to differentiate in vivo. The single cell assay is going to play a major role in unraveling the lineage and clonality of the enigmatic H/RS cell.
